Nantahala Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29M Hold
1,175,951
1.07% 22
2025
Q4
$19.9M Hold
1,175,951
0.66% 32
2025
Q3
$25.6M Hold
1,175,951
0.89% 24
2025
Q2
$16.8M Hold
1,175,951
0.66% 36
2025
Q1
$15.3M Buy
1,175,951
+57,468
+5% +$868K 0.61% 27
2024
Q4
$14.9M Buy
1,118,483
+119,750
+12% +$1.21M 0.64% 32
2024
Q3
$5.99M Buy
998,733
+58,000
+6% +$245K 0.3% 63
2024
Q2
$3.1M Buy
+940,733
New +$3.29M 0.18% 80

Other funds holding ETON

Nantahala Capital Management's ETON Position: Q1 2026 in Review

Nantahala Capital Management held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 1,175,951 shares worth $29M. The position accounts for 1.07% of the portfolio, ranked #22.

Nantahala Capital Management first reported a position in ETON in Q2 2024 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Nantahala Capital Management held 1,175,951 shares of Eton Pharmaceutcials worth $29M as of Q1 2026.
  • Nantahala Capital Management left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up 1.07% of Nantahala Capital Management's portfolio in Q1 2026, its #22 holding.
  • Nantahala Capital Management first reported a position in Eton Pharmaceutcials in Q2 2024 and has held it in 8 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.